|
|
| | hexyl aMino(4-aMinophenyl)MethylenecarbaMate hydrochloride Basic information |
| Product Name: | hexyl aMino(4-aMinophenyl)MethylenecarbaMate hydrochloride | | Synonyms: | hexyl aMino(4-aMinophenyl)MethylenecarbaMate hydrochloride;Dabigatran etexilate intermediate;Carbamic acid, N-[(4-aminophenyl)iminomethyl]-, hexyl ester, hydrochloride (1:1);hexyl (Z)-(amino(4-aminophenyl)methylene)carbamate hydrochloride;N-[(4-Aminophenyl)iminomethyl]carbamic acid hexyl ester hydrochloride;Dabigatran Impurity 6/Hexyl((4-Aminophenyl)(imino)methyl)carbamate Hydrochloride;Dabigatran etexilate-9;Dabigatran Ester Impurity V | | CAS: | 1307233-93-7 | | MF: | C14H22ClN3O2 | | MW: | 299.79638 | | EINECS: | | | Product Categories: | | | Mol File: | 1307233-93-7.mol |  |
| | hexyl aMino(4-aMinophenyl)MethylenecarbaMate hydrochloride Chemical Properties |
| solubility | DMSO (Slightly), Methanol (Slightly) | | form | Solid | | color | Light Yellow | | Stability: | Hygroscopic |
| | hexyl aMino(4-aMinophenyl)MethylenecarbaMate hydrochloride Usage And Synthesis |
| Uses | Hexyl ((4-Aminophenyl)(imino)methyl)carbamate Hydrochloride is the impurity of the antithrombotic drug Dabigatran Etexilate (D100150), which is nonpeptide direct thrombin inhibitor. |
| | hexyl aMino(4-aMinophenyl)MethylenecarbaMate hydrochloride Preparation Products And Raw materials |
|